loader2
Partner With Us NRI

Vimta Labs Ltd

Company details

306.05
321.30
292.85
540.00
6M Return -18.43%
1Y Return -20.94%
Mkt Cap.(Cr) 695.22
Volume 5,933
Div Yield 0.64%
OI
-
OI Chg %
-
Volume 5,933

Open Free Demat Account Online with ICICIDIRECT

FINANCIALS

Sales

Operating Profit

Profit after Tax

Equity

Reserves and Surplus

Debt

Sales

Operating Profit

Profit after Tax

PE

Debt/Equity

P BV

COMPARISION

INSIDER & INSTITUIONAL ACTIVITY

Equity Capital: 233.98 Cr FV: 2.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 22,728.09 -29,609.20
LAST 3M 42,048.80 -31,382.80
LAST 6M 65,127.04 16,114.05
LAST 12M 194,271.06 -118,498.61

Vimta Labs Limited - Analysts/Institutional Investor Meet/Con. Call Updates

Feb 03, 2023 l NSE Announcement

Vimta Labs Limited - Analysts/Institutional Investor Meet/Con. Call Updates

Feb 02, 2023 l NSE Announcement

Date Action Type Ratio
Jun 16, 2022 Dividend 100
Jun 25, 2021 Dividend 100

INFORMATION

Stock PE (TTM)

14.69

Promoter Holding

37.25%

Book Value

116.3009

ROCE

22.76%

ROE

19.3%

Description

  • Vimta Labs Ltd was Incorporated in the year 1990. The Laboratory was established in 1984 and developed a wide range of resources and testing capabilities. The Company is engaged in Contract Research and Analytical Testing Services. The Streams of Research and Testing are Contract Research (Clinical and Pre-clinical),Clinical Reference Laboratory Services (Central Lab), Analytical Testing of water,food,drugs etc.,and Environmental Monitoring and Impact Assessment. The Company was awarded ISO 9002 Certification under ISO/IEC Guide-25 as Certified Competent Laboratory and Quality Endorsed Company by Standards Australia Quality Assurance Services Pty. Ltd in 1994. In 1997, the Company entered into a Joint Venture with Russian Centre for Testing and Certification, ROSTEST Moscow with an investment of 24% of the total Paidup Captial. The main essence of this Joint Venture was to diversify the activities in to preshipment inspection services for all Indian exports to Russia. During 2002, the company begun to offer Clinical Diagnostics Services. Clinical Specialty Diagnostics has been an internal requirement to screen the clinical trial subjects. Facilities were created in the year 2000 to speed up the clinical trials. The Company is now expanding its operations by five times of its existing capacities at S P Biotech Park, Genome Valley, Turkapally Village, Shamirpet Mandal, Ranga Reddy Dist. The project is expected to commence from September 2005.

Registered Address

Plot No 141/2 & 142, IDA Phase II Cherlapally, Hyderabad, Telangana, 500051

Tel : 91-40-27264141
Email : shares:vimta.com
Website : http://www.vimta.com

Registrar

CIL Securities Limited

AGM Date (Month) : Jul
Face Value Equity Shares : 2
Market Lot Equity Shares : 1
BSE Code : 524394
NSE Code : VIMTALABS
Book Closure Date (Month) : Jun/Jul
BSE Group : B
ISIN : INE579C01029

ICICIdirect Vimta Labs Ltd FAQ

You can buy Vimta Labs Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Vimta Labs Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of Feb 08, 2023 04:01 PM the closing price of Vimta Labs Ltd was ₹ 314.25.
Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of Feb 08, 2023 04:01 PM, the market cap of Vimta Labs Ltd stood at ₹ 695.22.
The latest PE ratio of Vimta Labs Ltd as of Feb 08, 2023 04:01 PM is 14.69
The latest PB ratio of Vimta Labs Ltd as of Feb 08, 2023 04:01 PM is 0.37
The 52-week high of Vimta Labs Ltd is ₹ 540.00 while the 52-week low is ₹ 292.85

Download Our App

market app
market app